Jimmy is a seasoned leader in AI-driven drug discovery (AIDD) and computer-aided drug design (CADD), with a strong track record in advancing new drug programs. As the former CEO of Insilico Medicine Taiwan, he has led groundbreaking work at the intersection of AI and quantum research and successfully driven multiple strategic business deals. A recognized thought leader in AIDD landscape, Jimmy also serves as an Adjunct Assistant Professor at National Yang Ming Chiao Tung University (NYCU), Taiwan. He earned his bachelor's degree from the Department of Pharmacy at National Taiwan University (NTU) and his PhD from ETH Zurich in computational chemistry. He completed postdoctoral research at Harvard University and A*STAR.